205 related articles for article (PubMed ID: 32107136)
1. Endometrial cancer prevention in high-risk women.
Njoku K; Abiola J; Russell J; Crosbie EJ
Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():66-78. PubMed ID: 32107136
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma of the endometrium.
Southcott BM
Drugs; 2001; 61(10):1395-405. PubMed ID: 11558829
[TBL] [Abstract][Full Text] [Related]
3. Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?
Mills KA; Joshi TV; West L; Kuznicki M; Kent L; Hokenstad AN; Cripe JC; Woolfolk C; Senter L; Bakkum-Gamez JN; Wenham RM; Cohn DE; Bae-Jump V; Thaker PH
Gynecol Oncol; 2020 Jun; 157(3):706-710. PubMed ID: 32143914
[TBL] [Abstract][Full Text] [Related]
4. Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm.
Gasparri ML; Taghavi K; Fiacco E; Zuber V; Di Micco R; Gazzetta G; Valentini A; Mueller MD; Papadia A; Gentilini OD
Medicina (Kaunas); 2019 Jul; 55(8):. PubMed ID: 31362334
[TBL] [Abstract][Full Text] [Related]
5. Atypical endometrial polyps and the incidence of endometrial cancer: a retrospective cohort study.
Jacobs I; Tibosch R; Geomini P; Coppus S; Bongers MY; van Hanegem N
BJOG; 2020 Jul; 127(8):994-999. PubMed ID: 32133762
[TBL] [Abstract][Full Text] [Related]
6. Identifying High-Risk Women for Endometrial Cancer Prevention Strategies: Proposal of an Endometrial Cancer Risk Prediction Model.
Kitson SJ; Evans DG; Crosbie EJ
Cancer Prev Res (Phila); 2017 Jan; 10(1):1-13. PubMed ID: 27965288
[TBL] [Abstract][Full Text] [Related]
7. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review.
Tinelli A; Vergara D; Martignago R; Leo G; Malvasi A; Tinelli R
Acta Obstet Gynecol Scand; 2008; 87(11):1101-13. PubMed ID: 18607816
[TBL] [Abstract][Full Text] [Related]
8. [Risk-reducing surgery in women at hereditary risk of gynaecological cancer].
Zikán M
Ceska Gynekol; 2011 Jun; 76(3):216-21. PubMed ID: 21838153
[TBL] [Abstract][Full Text] [Related]
9. Cancer Risk-Reducing Opportunities in Gynecologic Surgery.
Piszczek C; Ma J; Gould CH; Tseng P
J Minim Invasive Gynecol; 2018; 25(7):1179-1193. PubMed ID: 29097232
[TBL] [Abstract][Full Text] [Related]
10. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
[TBL] [Abstract][Full Text] [Related]
11. Unexpected endometrial cancer at prophylactic hysterectomy in a woman with hereditary nonpolyposis colon cancer.
Chung L; Broaddus R; Crozier M; Luthraa R; Levenback C; Lu K
Obstet Gynecol; 2003 Nov; 102(5 Pt 2):1152-5. PubMed ID: 14607039
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Schmeler KM; Lynch HT; Chen LM; Munsell MF; Soliman PT; Clark MB; Daniels MS; White KG; Boyd-Rogers SG; Conrad PG; Yang KY; Rubin MM; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
N Engl J Med; 2006 Jan; 354(3):261-9. PubMed ID: 16421367
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
[TBL] [Abstract][Full Text] [Related]
14. Endometrial patterns and endocrinologic characteristics of asymptomatic menopausal women.
Göl K; Saraçoğlu F; Ekici A; Sahin I
Gynecol Endocrinol; 2001 Feb; 15(1):63-7. PubMed ID: 11293927
[TBL] [Abstract][Full Text] [Related]
15. Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy.
Saule C; Mouret-Fourme E; Briaux A; Becette V; Rouzier R; Houdayer C; Stoppa-Lyonnet D
J Natl Cancer Inst; 2018 Feb; 110(2):. PubMed ID: 28954295
[TBL] [Abstract][Full Text] [Related]
16. Cancer Incidence in Patients with Atypical Endometrial Hyperplasia Managed by Primary Hysterectomy or Fertility-sparing Treatment.
Gonthier C; Piel B; Touboul C; Walker F; Cortez A; Luton D; Daraï E; Koskas M
Anticancer Res; 2015 Dec; 35(12):6799-804. PubMed ID: 26637899
[TBL] [Abstract][Full Text] [Related]
17. Hormone prevention strategies for breast, endometrial and ovarian cancers.
Rice LW
Gynecol Oncol; 2010 Aug; 118(2):202-7. PubMed ID: 20471672
[TBL] [Abstract][Full Text] [Related]
18. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
[TBL] [Abstract][Full Text] [Related]
19. Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature.
Dogan A; Schultheis B; Rezniczek GA; Hilal Z; Cetin C; Häusler G; Tempfer CB
Anticancer Res; 2017 Mar; 37(3):969-978. PubMed ID: 28314254
[TBL] [Abstract][Full Text] [Related]
20. The gynecological surveillance of women with Lynch syndrome in Sweden.
Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
